ABSTRACT
Background Altered patterns of eye-movements during scene exploration, and atypical gaze preferences in social settings, have long been noted as features of the Autism phenotype. While these are typically attributed to differences in social engagement and interests (e.g., preferences for inanimate objects over face stimuli), there are also reports of differential saccade measures to non-social stimuli, raising the possibility that fundamental differences in visuo-sensorimotor processing may be at play. Here, we tested the plasticity of the eye-movement system using a classic saccade-adaptation paradigm to assess whether individuals with ASD make typical adjustments to their eye-movements in response to experimentally introduced errors. Saccade adaptation can be measured in infants as young as 10 months, raising the possibility that such measures could be useful as early neuromarkers of ASD risk.
Methods Saccade amplitudes were measured while children and adults with ASD (N=41) and age-matched typically developing (TD) individuals (N=68) made rapid eye-movements to peripherally presented targets. During adaptation trials, the target was relocated from 20-degrees to 15-degrees from fixation once a saccade to the original target location was initiated, a manipulation that leads to systematic reduction in saccade amplitudes in typical observers.
Results Neither children nor adults with ASD showed any differences relative to TD peers in their abilities to appropriately adapt saccades in the face of persistently introduced errors.
Conclusions Of the three studies to date of saccade adaptation in ASD, none have shown frank deficits in saccade adaptation. Unlike prior studies, we found no evidence for a slower adaptation rate during the early adaptation phase, and no of evidence greater variance of saccade amplitudes in ASD. In post-hoc analysis, there was evidence for larger primary saccades to non-adapted targets, a finding requiring replication in future work.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Initial funding for this work was provided through a pilot grant to EGF and JJF from the Schmitt Program on Integrative Neuroscience (SPIN), administered through the Del Monte Institute for Neuroscience at the University of Rochester. Eye-movement recordings were conducted at the Translational Neuroimaging and Neurophysiology Core and participant phenotyping was conducted at the Human Recruitment and Phenotyping Core of the University of Rochester Intellectual and Developmental Disabilities Research Center (UR-IDDRC), which is supported by a center grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50 HD103536 to JJF). Phenotyping and eye-tracking at the Albert Einstein collaborating site were conducted through the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (RFK-IDDRC), which is supported by a center grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50 HD105352 to SM).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Research Subjects Review Boards of the University of Rochester and the Albert Einstein College of Medicine approved all the experimental procedures (respectively STUDY00002036 and 2009-523). All adult participants provided written informed consent and for all individuals below 18 their parents provided written informed consent and each participant in this age range provided written informed assent in accordance with the tenets laid out in the Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Upon acceptance for publication, the authors will coordinate with the editorial office to ensure that the full and appropriately de-identified datasets are uploaded to a publicly available repository and that the appropriate link is made to the article file (e.g. Figshare, Dryad).
Abbreviations
- ASD
- Autism Spectrum Disorder
- TD
- Typically Developing
- ANCOVA
- Analysis of Covariance
- HFA
- High Functioning Autism
